Lymph Node Macrophages Restrict Murine Cytomegalovirus Dissemination.
Cytomegaloviruses (CMVs) establish chronic infections that spread from a primary entry site to secondary vascular sites, such as the spleen, and then to tertiary shedding sites, such as the salivary glands. Human CMV (HCMV) is difficult to analyze, because its spread precedes clinical presentation. Murine CMV (MCMV) offers a tractable model. It is hypothesized to spread from peripheral sites via vascular endothelial cells and associated monocytes. However, viral luciferase imaging showed footpad-inoculated MCMV first reaching the popliteal lymph nodes (PLN). PLN colonization was rapid and further spread was slow, implying that LN infection can be a significant bottleneck. Most acutely infected PLN cells were CD169(+) subcapsular sinus macrophages (SSM). Replication-deficient MCMV also reached them, indicating direct infection. Many SSM expressed viral reporter genes, but few expressed lytic genes. SSM expressed CD11c, and MCMV with a cre-sensitive fluorochrome switch showed switched infected cells in PLN of CD11c-cre mice but yielded little switched virus. SSM depletion with liposomal clodronate or via a CD169-diphtheria toxin receptor transgene shifted infection to ER-TR7(+) stromal cells, increased virus production, and accelerated its spread to the spleen. Therefore, MCMV disseminated via LN, and SSM slowed this spread by shielding permissive fibroblasts and poorly supporting viral lytic replication.


OBJECTIVE
HCMV chronically infects most people, and it can cause congenital disability and harm the immunocompromised. A major goal of vaccination is to prevent systemic infection. How this is established is unclear. Restriction to humans makes HCMV difficult to analyze. We show that peripheral MCMV infection spreads via lymph nodes. Here, MCMV infected filtering macrophages, which supported virus replication poorly. When these macrophages were depleted, MCMV infected susceptible fibroblasts and spread faster. The capacity of filtering macrophages to limit MCMV spread argued that their infection is an important bottleneck in host colonization and might be a good vaccine target.
Sir Albert Sakzewski Virus Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland and Royal Children's Hospital, Brisbane, Queensland, Australia.
Helen E
HE
Farrell
Sir Albert Sakzewski Virus Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland and Royal Children's Hospital, Brisbane, Queensland, Australia.
Nick
N
Davis-Poynter
Sir Albert Sakzewski Virus Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland and Royal Children's Hospital, Brisbane, Queensland, Australia.
Kimberley
K
Bruce
Sir Albert Sakzewski Virus Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland and Royal Children's Hospital, Brisbane, Queensland, Australia.
Clara
C
Lawler
Institut für Molekulare Infektionsbiologie, University of Würzburg, Würzburg, Germany.
Lars
L
Dolken
Institut für Klinische und Molekulare Virologie, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Michael
M
Mach
Sir Albert Sakzewski Virus Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland and Royal Children's Hospital, Brisbane, Queensland, Australia p.stevenson@uq.edu.au.
Philip G
PG
Stevenson
D000818:Animals; D004195:Disease Models, Animal; D006566:Herpesviridae Infections / Q000276:immunology* / Q000821:virology*; D047589:Leukocyte Reduction Procedures; D008198:Lymph Nodes / Q000276:immunology* / Q000821:virology*; D008264:Macrophages / Q000276:immunology* / Q000821:virology*; D051379:Mice; D018146:Muromegalovirus / Q000276:immunology*; D012469:Salivary Glands / Q000821:virology; D013154:Spleen / Q000821:virology